NewAmsterdam Pharma Company (NasdaqGM:NAMS) 2025 Conference Transcript

NewAmsterdam Pharma Company (NasdaqGM:NAMS) 2025 Conference November 19, 2025 07:00 AM ET Speaker1Hi, good afternoon. Welcome to the Jefferies London Healthcare Conference. My name is Dennis Thing, biotech analyst here at Jefferies. I have the wonderful pleasure of having NewAmsterdam Pharma here. We have the CSO, John Kastelein, and CFO, Ian Somaiya, here with us. Welcome.Speaker0Thank you.Speaker1Maybe to kick things off, just talk about obicetrapib as a molecule, what you are trying to achieve with that ...